134 related articles for article (PubMed ID: 19493708)
1. A high-performance liquid chromatography-mass spectrometry assay for quantitation of the tyrosine kinase inhibitor nilotinib in human plasma and serum.
Parise RA; Egorin MJ; Christner SM; Shah DD; Zhou W; Beumer JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1894-900. PubMed ID: 19493708
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic assay for the determination of nilotinib in human plasma.
Yuki M; Yamakawa Y; Uchida T; Nambu T; Kawaguchi T; Hamada A; Saito H
Biol Pharm Bull; 2011; 34(7):1126-8. PubMed ID: 21720025
[TBL] [Abstract][Full Text] [Related]
3. New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.
De Francia S; D'Avolio A; De Martino F; Pirro E; Baietto L; Siccardi M; Simiele M; Racca S; Saglio G; Di Carlo F; Di Perri G
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jun; 877(18-19):1721-6. PubMed ID: 19428316
[TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatography with solid-phase extraction for the quantitative determination of nilotinib in human plasma.
Miura M; Takahashi N; Sawada K
Biomed Chromatogr; 2010 Jul; 24(7):789-93. PubMed ID: 19904720
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma.
Parise RA; Ramanathan RK; Hayes MJ; Egorin MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):39-44. PubMed ID: 12798163
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of ruxolitinib and nilotinib in rat plasma by LC-MS/MS: application to a pharmacokinetic study.
Veeraraghavan S; Thappali S; Viswanadha S; Chennupati S; Nalla S; Golla M; Vakkalanka S; Rangasamy M
J Pharm Biomed Anal; 2014 Jun; 94():125-31. PubMed ID: 24561338
[TBL] [Abstract][Full Text] [Related]
7. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
[TBL] [Abstract][Full Text] [Related]
8. High-throughput liquid chromatography/electrospray ionization-tandem mass spectrometry method using in-source collision-induced dissociation for simultaneous quantification of imatinib, dasatinib, bosutinib, nilotinib, and ibrutinib in human plasma.
Hirasawa T; Kikuchi M; Shigeta K; Takasaki S; Sato Y; Sato T; Ogura J; Onodera K; Fukuhara N; Onishi Y; Maekawa M; Mano N
Biomed Chromatogr; 2021 Aug; 35(8):e5124. PubMed ID: 33772839
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of the immunosuppressant CP-690,550 in whole blood by column-switching high-performance liquid chromatography and mass spectrometry detection.
Paniagua R; Campbell A; Changelian PS; Reitz BA; Prakash C; Borie DC
Ther Drug Monit; 2005 Oct; 27(5):608-16. PubMed ID: 16175134
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography-mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerase.
Parise RA; Shawaqfeh M; Egorin MJ; Beumer JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):141-7. PubMed ID: 18692448
[TBL] [Abstract][Full Text] [Related]
11. A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
van Erp NP; de Wit D; Guchelaar HJ; Gelderblom H; Hessing TJ; Hartigh Jd
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():33-43. PubMed ID: 24013127
[TBL] [Abstract][Full Text] [Related]
12. Determination of voriconazole in human plasma by HPLC-ESI-MS and application to pharmacokinetic study.
Lin D; Li G; Chen L
J Chromatogr Sci; 2013 Jul; 51(6):485-9. PubMed ID: 23147034
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry.
Kralj E; Trontelj J; Pajič T; Kristl A
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():150-6. PubMed ID: 22857863
[TBL] [Abstract][Full Text] [Related]
14. A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients.
Pirro E; De Francia S; De Martino F; Fava C; Ulisciani S; Cambrin GR; Racca S; Saglio G; Di Carlo F
J Chromatogr Sci; 2011; 49(10):753-7. PubMed ID: 22080802
[TBL] [Abstract][Full Text] [Related]
15. High-performance Liquid Chromatographic Ultraviolet Detection of Nilotinib in Human Plasma from Patients with Chronic Myelogenous Leukemia, and Comparison with Liquid Chromatography-Tandem Mass Spectrometry.
Nakahara R; Satho Y; Itoh H
J Clin Lab Anal; 2016 Nov; 30(6):1028-1030. PubMed ID: 27194024
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Determination of Imatinib, Dasatinib, and Nilotinib by Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Therapeutic Drug Monitoring.
Wojnicz A; Colom-Fernández B; Steegmann JL; Muñoz-Calleja C; Abad-Santos F; Ruiz-Nuño A
Ther Drug Monit; 2017 Jun; 39(3):252-262. PubMed ID: 28490048
[TBL] [Abstract][Full Text] [Related]
17. HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC).
D'Avolio A; Simiele M; De Francia S; Ariaudo A; Baietto L; Cusato J; Fava C; Saglio G; Di Carlo F; Di Perri G
J Pharm Biomed Anal; 2012 Feb; 59():109-16. PubMed ID: 22036594
[TBL] [Abstract][Full Text] [Related]
18. Imatinib assay by high-performance liquid chromatography in tandem mass spectrometry with solid-phase extraction in human plasma.
Moreno JM; Wojnicz A; Steegman JL; Cano-Abad MF; Ruiz-Nuño A
Biomed Chromatogr; 2013 Apr; 27(4):502-8. PubMed ID: 23034891
[TBL] [Abstract][Full Text] [Related]
19. An aqueous normal-phase chromatography coupled with tandem mass spectrometry method for determining unbound brain-to-plasma concentration ratio of AZD1775, a Wee1 kinase inhibitor, in patients with glioblastoma.
Wu J; Sanai N; Bao X; LoRusso P; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():25-32. PubMed ID: 27318641
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of sacubitrilat and fimasartan in rat plasma by a triple quad liquid chromatography-tandem mass spectrometry method utilizing electrospray ionization in positive mode.
Giri P; Joshi V; Giri S; Delvadia P; Jain MR
Biomed Chromatogr; 2021 Feb; 35(2):e4981. PubMed ID: 32895916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
